552 related articles for article (PubMed ID: 36629404)
1. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
Elife; 2023 Jan; 12():. PubMed ID: 36629404
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
4. Aging, hematopoiesis, and the myelodysplastic syndromes.
Chung SS; Park CY
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):73-78. PubMed ID: 29222239
[TBL] [Abstract][Full Text] [Related]
5. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
[TBL] [Abstract][Full Text] [Related]
6. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes.
Berastegui N; Ainciburu M; Romero JP; Garcia-Olloqui P; Alfonso-Pierola A; Philippe C; Vilas-Zornoza A; San Martin-Uriz P; Ruiz-Hernández R; Abarrategi A; Ordoñez R; Alignani D; Sarvide S; Castro-Labrador L; Lamo-Espinosa JM; San-Julian M; Jimenez T; López-Cadenas F; Muntion S; Sanchez-Guijo F; Molero A; Montoro MJ; Tazón B; Serrano G; Diaz-Mazkiaran A; Hernaez M; Huerga S; Bewicke-Copley F; Rio-Machin A; Maurano MT; Díez-Campelo M; Valcarcel D; Rouault-Pierre K; Lara-Astiaso D; Ezponda T; Prosper F
Nat Commun; 2022 Dec; 13(1):7619. PubMed ID: 36494342
[TBL] [Abstract][Full Text] [Related]
8. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
[TBL] [Abstract][Full Text] [Related]
9. Why Single-Cell Sequencing Has Promise in MDS.
Zhang X; Grimes HL
Front Oncol; 2021; 11():769753. PubMed ID: 34926276
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms.
Zeng X; Wang Y; Dai M; Li W; Huang Q; Qin L; Li Y; Yan Y; Xue X; Yi F; Li W; He L; Liu Q; Qi L
J Transl Med; 2024 Apr; 22(1):359. PubMed ID: 38632656
[TBL] [Abstract][Full Text] [Related]
11. Is Myelodysplasia a Consequence of Normal Aging?
Heibl S; Stauder R; Pfeilstöcker M
Curr Oncol Rep; 2021 Nov; 23(12):142. PubMed ID: 34735656
[TBL] [Abstract][Full Text] [Related]
12. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.
Matos A; Magalhães SMM; Rauh MJ
Adv Exp Med Biol; 2021; 1326():1-10. PubMed ID: 33385175
[TBL] [Abstract][Full Text] [Related]
13. Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
Wobus M; Mies A; Asokan N; Oelschlägel U; Möbus K; Winter S; Cross M; Weidner H; Rauner M; Hofbauer LC; Bornhäuser M; Platzbecker U
Leukemia; 2021 Oct; 35(10):2936-2947. PubMed ID: 34002031
[TBL] [Abstract][Full Text] [Related]
14. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
[TBL] [Abstract][Full Text] [Related]
15. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.
Ostendorf BN; Flenner E; Flörcken A; Westermann J
PLoS One; 2018; 13(5):e0197823. PubMed ID: 29799854
[TBL] [Abstract][Full Text] [Related]
17. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic
Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
[TBL] [Abstract][Full Text] [Related]
19. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
20. FAK Deficiency in Bone Marrow Stromal Cells Alters Their Homeostasis and Drives Abnormal Proliferation and Differentiation of Haematopoietic Stem Cells.
Wu Y; Campos L; Daguenet E; He Z; Picot T; Tavernier-Tardy E; Soglu G; Guyotat D; Aanei CM
Cells; 2020 Mar; 9(3):. PubMed ID: 32155953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
